S&P: Baxter unaffected

Standard & Poor's said its ratings and outlook on Baxter International Inc. (A/Positive/--) are unaffected by the company's continuing infusion pump problems given the negligible financial impact.

S&P said it would monitor the company's progress in resolving those issues to determine if any potential loss in customer confidence translates into broader concerns regarding the company's franchise.

Given the company's performance despite the loss of Colleague sales over the past year and a half, there is potential for an upgrade in the next two to three years, S&P said.

But that view could change if customer relationships and other areas of the business suffer due to ongoing problems, the agency said.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.